Heiko Kroth
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents 5
- Virology top 5%
- Molecular Biology top 10%
- DNA and Nucleic Acid Chemistry 20
- DNA Repair Mechanisms 11
- Cancer therapeutics and mechanisms 9
- Cancer Research top 10%
- Physiology top 10%
- Alzheimer's disease research and treatments 13
-
- HIV/AIDS drug development and treatment 7
-
- Computational Drug Discovery Methods 6
-
- Cholinesterase and Neurodegenerative Diseases 6
- Co-authors
- Donald M. JerinaJane M. SayerYves PommierAndrea PfeiferGlenda KohlhagenClaude NicolauGary S. LacoА. В. Елисеев
- Cited by
- ToxicologyVirologyMolecular Biology
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Journal of the American Chemical Society (1 paper)Journal of Biological Chemistry (9 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Heiko Kroth
55 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 91
- Toxicology 100
- Virology 80
- Molecular Biology 931
- Cancer Research 176
- Physiology 303
Countries citing papers authored by Heiko Kroth
This map shows the geographic impact of Heiko Kroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heiko Kroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heiko Kroth more than expected).
Fields of papers citing papers by Heiko Kroth
This network shows the impact of papers produced by Heiko Kroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heiko Kroth. The network helps show where Heiko Kroth may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Heiko Kroth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 8 | |
| 3 | 2021 | 7 | |
| 4 | 2020 | 6 | |
| 5 | 2019 | 134 | |
| 6 | 2019 | 3 | |
| 7 | 2017 | 22 | |
| 8 | 2016 | 12 | |
| 9 | 2012 | 46 | |
| 10 | 2005 | 15 | |
| 11 | 2003 | 15 | |
| 12 | 2003 | 18 | |
| 13 | 2003 | 67 | |
| 14 | 2003 | 12 | |
| 15 | 2002 | 118 | |
| 16 | 2002 | 77 | |
| 17 | 2002 | 34 | |
| 18 | 2001 | 20 | |
| 19 | 2000 | 55 | |
| 20 | [Cornelia de Lange syndrome I in twins (Amsterdam type of degeneration)]. | 1966 | 4 |
About Heiko Kroth
Heiko Kroth is a scholar working on Toxicology, Physiology and Molecular Biology, having authored 55 papers that have together received 1.5k indexed citations. Recurring topics across this work include DNA and Nucleic Acid Chemistry (20 papers), Alzheimer's disease research and treatments (13 papers), DNA Repair Mechanisms (11 papers), Cancer therapeutics and mechanisms (9 papers), HIV/AIDS drug development and treatment (7 papers), Computational Drug Discovery Methods (6 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Bioactive Compounds and Antitumor Agents (5 papers). The work is most often cited by research in Toxicology (100 citations), Virology (80 citations) and Molecular Biology (931 citations). Heiko Kroth has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Donald M. Jerina, Jane M. Sayer, Yves Pommier, Andrea Pfeifer, Glenda Kohlhagen, Claude Nicolau, Gary S. Laco, А. В. Елисеев, Matthias Hochgürtel and Otmar Schaaf. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.